bone

Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment

Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for…

4 hours ago

Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market

SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight…

2 weeks ago

Sussex man to paddleboard across English Channel in daughters memory in huge charity challenge

Wednesday 2 July, 2025 A Sussex man is preparing to paddleboard across the English Channel to raise funds for children’s…

2 months ago